Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes

Background: Host- and pathogen-related factors associated with septic shock in pneumococcal pneumonia are not well defined. The aim of this study was to identify risk factors for septic shock and to ascertain patient outcomes. Serotypes, genotypes and antibiotic resistance of isolated strains were also analysed. Methods: Observational analysis of a prospective cohort of non-severely immunosuppressed hospitalised adults with pneumococcal pneumonia. Septic shock was defined as a systolic blood pressure of <90 mm Hg and peripheral hypoperfusion with the need for vasopressors for >4 h after fluid replacement. Results: 1041 patients with pneumococcal pneumonia diagnosed by Gram stain and culture of appropriate samples and/or urine antigen test were documented, of whom 114 (10.9%) had septic shock at admission. After adjustment, independent risk factors for shock were current tobacco smoking (OR, 2.11; 95% CI, 1.02 to 4.34; p = 0.044), chronic corticosteroid treatment (OR, 4.45; 95% CI, 1.75 to 11.32; p = 0.002) and serotype 3 (OR, 2.24; 95% CI, 1.12 to 4.475; p = 0.022). No significant differences were found in genotypes and rates of antibiotic resistance. Compared with the remaining patients, patients with septic shock required mechanical ventilation more frequently (37% vs 4%; p<0.001) and had longer length of stay (11 vs 8 days; p<0.001). The early (10% vs 1%; p<0.001) and overall case fatality rates (25% vs 5%; p<0.001) were higher in patients with shock. Conclusions: Septic shock is a frequent complication of pneumococcal pneumonia and causes high morbidity and mortality. Current tobacco smoking, chronic corticosteroid treatment and infection caused by serotype 3 are independent risk factors for this complication.

[1]  R. Veenhoven,et al.  Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  G. Hanquet,et al.  Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007 , 2009, Journal of Clinical Microbiology.

[3]  J. Dorca,et al.  Early mortality in patients with community-acquired pneumonia: causes and risk factors , 2008, European Respiratory Journal.

[4]  J. Hasday,et al.  Tobacco Smoking Inhibits Expression of Proinflammatory Cytokines and Activation of IL-1R-Associated Kinase, p38, and NF-κB in Alveolar Macrophages Stimulated with TLR2 and TLR4 Agonists1 , 2007, The Journal of Immunology.

[5]  J. Rello,et al.  Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Bates,et al.  Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. , 2007, Archives of internal medicine.

[7]  J. McCullers Insights into the Interaction between Influenza Virus and Pneumococcus , 2006, Clinical Microbiology Reviews.

[8]  T. Marrie,et al.  Bacteremic Pneumococcal Pneumonia: A Prospective Study in Edmonton and Neighboring Municipalities , 2005, Medicine.

[9]  T. Benfield,et al.  Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited , 2004, BMC infectious diseases.

[10]  N. Tritos Corticosteroid insufficiency in acutely ill patients. , 2003, The New England journal of medicine.

[11]  M. Fine,et al.  Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. , 2002, Archives of internal medicine.

[12]  M. Sopori,et al.  Effects of cigarette smoke on the immune system , 2002, Nature Reviews Immunology.

[13]  J. Dorca,et al.  Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  A. Tomasz,et al.  Nomenclature of Major Antimicrobial-Resistant Clones of Streptococcus pneumoniae Defined by the Pneumococcal Molecular Epidemiology Network , 2001, Journal of Clinical Microbiology.

[15]  T. Marrie,et al.  Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. , 2000, The Journal of infectious diseases.

[16]  M. Kolczak,et al.  Cigarette smoking and invasive pneumococcal disease , 2000 .

[17]  A. Schuchat,et al.  Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. , 2000, American journal of public health.

[18]  D. Crook,et al.  Population biology of Streptococcus pneumoniae isolated from oropharyngeal carriage and invasive disease. , 1999, Microbiology.

[19]  B. Spratt,et al.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. , 1998, Microbiology.

[20]  Inger,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[21]  T. File,et al.  Risk factors for domestic acquisition of legionnaires disease. Ohio legionnaires Disease Group , 1996 .

[22]  M. Fine,et al.  Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. , 1996, JAMA.

[23]  J. Henrichsen,et al.  Six newly recognized types of Streptococcus pneumoniae , 1995, Journal of clinical microbiology.

[24]  R. Hirschtick,et al.  Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. , 1995, The New England journal of medicine.

[25]  E. Bleecker,et al.  Altered cytokine regulation in the lungs of cigarette smokers. , 1994, American journal of respiratory and critical care medicine.

[26]  I. Phillips,et al.  Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. , 1985, British medical journal.

[27]  J. Kark,et al.  Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. , 1982, The New England journal of medicine.

[28]  M. Finland,et al.  Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974 , 1977, Journal of clinical microbiology.

[29]  R. Austrian,et al.  PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA. , 1964, Annals of internal medicine.

[30]  D. Rolo,et al.  Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Alexander Rokitansky,et al.  Thorax , 2009, Pediatric Surgery Digest.

[32]  M. Maiden,et al.  Multilocus sequence typing. , 2009, Methods in molecular biology.

[33]  T. van der Poll,et al.  Host-pathogen interactions in sepsis. , 2008, The Lancet. Infectious diseases.

[34]  E. García,et al.  Clonal origin of the type 37 Streptococcus pneumoniae. , 2000, Microbial drug resistance.

[35]  M. Kolczak,et al.  Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. , 2000, The New England journal of medicine.

[36]  A. Tomasz Streptococcus pneumoniae : molecular biology & mechanisms of disease , 2000 .

[37]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[38]  S. Jain,et al.  Population Biology , 1990, Springer Berlin Heidelberg.

[39]  J. Waitz Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .